Voxelotor for the Treatment of Sickle Cell Disease - ScienceDirect
Taking Oxbryta
Uganda Sickle Cell Rescue Foundation - Oxbryta medication approved by US FDA in 2019 to treat sickle cell disease in adults and children 12 years of age and older. What's your experience? *
FDA Approves Voxelotor for Sickle Cell Disease - The ASCO Post
Voxelotor - Wikipedia
Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action - Green - 2022 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease - ScienceDirect
Voxelotor recommended dosage for concomitant medications. | Download Scientific Diagram
GBT heads to FDA with sickle cell drug voxelotor | pharmaphorum
FDA Lowers Age Indication for Oxbryta to Treat Younger Children With Sickle Cell Disease - Pharmacy Practice News
Oxbryta (voxelotor) - Rare Disease Advisor
Voxelotor - Wikipedia
10-K
TEAEs occurring in >1 healthy volunteer receiving 15 days of voxelotor... | Download Scientific Diagram
A Gram-Daily Aldehyde for Anemia: Voxelotor - Drug Hunter
Oxbryta (voxelotor)- Sickle cell disease- by Saro Arakelians, PharmD- Episode #29 - YouTube
Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review | Article
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease | NEJM
Ascending Dose Study Demonstrates Safety, Efficacy of Voxelotor in Sickle Cell Disease
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease | NEJM
Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action - Green - 2022 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
EHA Library - The official digital education library of European Hematology Association (EHA)
